Moberg Pharma
10.28 SEK
-0.96 %
Less than 1K followers
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Moberg Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.9 | 1.0 | 9.8 | 3.9 | 3.6 | 4.0 | 2.1 | 13.5 |
| EBITDA | -3.0 | -7.8 | -23.5 | -3.7 | -9.3 | -5.6 | -7.1 | -25.7 |
| EBIT | -3.3 | -308.1 | -324.8 | -4.1 | -9.7 | -6.0 | -7.5 | -27.3 |
| EBIT-% | -85.5 % | -29,915.5 % | -3,311.2 % | -106.7 % | -270.3 % | -149.8 % | -360.4 % | -201.8 % |
| Profit before taxes | -1.6 | -306.0 | -320.5 | -3.2 | -8.7 | -5.2 | -7.0 | -24.0 |
| Net income | -1.3 | -243.3 | -255.1 | -2.8 | -7.4 | -4.3 | -12.8 | -27.2 |